Ado-Trastuzumab Emtansine Targets Hepatocytes via Human Epidermal Growth Factor Receptor 2 to Induce Hepatotoxicity
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0580
Full Text
Open PDFAbstract
Available in full text
Date
December 28, 2015
Authors
Publisher
American Association for Cancer Research (AACR)